The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder. ResMed makes continuous positive ...
Robert F. Kennedy Jr., President Trump’s nominee for Health and Human Services (HHS) secretary, sat through his second Senate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback